[Spondylarthropathy with Behçet's disease: response to infliximab].
Toussirot
Eric
E
Service de Rhumatologie, CHU Hôpital Minjoz, EA 3186 Agents Pathogènes et Inflammation, Université de Franche-Comté, F-25000 Besançon, France. etoussirot@chu-besancon.fr
Schwartz
Claire
C
Hafsaoui
Chafika
C
Bossert
Marie
M
Bertolini
Ewa
E
Wendling
Daniel
D
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001528:Behcet Syndrome / Q000150:complications*; D006801:Humans; D000069285:Infliximab; D008297:Male; D025242:Spondylarthropathies / Q000150:complications* / Q000000981:diagnostic imaging / Q000378:metabolism; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab